Background
Methods
Design
Setting and participants
Theoretical foundation and implementation strategies
Interventional components and activities
Learning lab content | |
– Lecture on infection prevention, fluid balance and pre-optimisation in elderly patients. – Expert nurses and researcher review the literature. –Refresh assessment and communication tools: SBAR [43‐45], early warning score and triage toola [46‐48], ABCDE + F [49, 50], specifically related to patients’ need for catheterisation or not, CRM: decision-making, situational awareness and prioritisation related to urinary catheterisation [51, 52]. – Encourage thinking together i.e. ask a peer or physician for support in the decision process if needed, as a sign of growth, not a weakness. – Dialogue relating to: i. Evidence-based catheter indications and removal plan and alternative to IDC such as suprapubic catheter. ii. Patient cases. iii. The risk of self-termination of invasive devices, which can occur in patients with cognitive dysfunction or acute confusion. iv. The use of straight in-out catheterisation or alternative to indwelling urinary catheter. v. Appropriate documentation to prevent the loss of information. vi. Patient involvement i.e. to see them as competent individuals and experts on their body and function [53]. | |
Practical procedure | |
– Co-creating the nurse-driven urinary catheterisation protocol. – Introduce the national schedule for measuring residual urine via a portable bladder scanner, adapted to fit the study site bladder volume threshold of ≥400 ml, starting on admission [54], see below. – If in need of straight in-out catheterisation before transport to the pre-operative area, or a pre-operative urine volume of ≥200 ml before start of anaesthesia and anticipated > 3 hours to end of surgery, insert an indwelling catheter and remove within 24–48 hours. – If no catheter, perform bladder scan immediately at the end of surgery, after wound closure and continuous post-operatively according to the schedule. – Use a catheter with a thermistor to facilitate peri-operative measurement of patients’ temperature. – Document indication, removal plan and perform a daily evaluation for catheter placed > 48 hours. – Developed pocket-sized stickers with indication, removal plan and scanning schedule. | |
Bladder scanning schedule Residual urine: 100–150 ml – control after three hours 150–300 ml – control after two hours 300–400 ml – control after one hour ≥400 ml – perform straight in-out catheterisation or indwelling catheter depending on patient assessment, patient involvement and the further care plan |
The implementation process of the nurse-driven urinary catheterisation protocol
Data collection
Assessment of the protocol nurse-driven urinary catheterisation protocol
Statistical analysis
Results
Primary outcome
Variables | Year 1, June 2015-May 2016 | Year 2, June 2016-May 2017 | Year 3, June 2017-May 2018 | Year 4, June 2018-May 2019 | Year 5, June 2019 March 2020 | p Over the periods |
---|---|---|---|---|---|---|
Patients’ characteristics | n = 406 | n = 655 | n = 700 | n = 691 | n = 626 | |
Age, years | 83.8 (8.0), 85 (79; 90) | 84.8 (7.7), 86 (80; 91) | 83.9 (8.3), 85 (78; 90) | 83.9 (8.3), 85 (78; 90) | 83.6 (8.2), 84 (77; 90) | 0.091 |
Gender, female | 294 (72.4) | 446 (68.1) | 493 (70.4) | 501 (72.5) | 443 (70.8) | 0.63 |
ASA | ||||||
I | 15 (3.7) | 14 (2.1) | 11 (1.6) | 29 (4.2) | 16 (2.6) | |
II | 165 (40.6) | 264 (40.3) | 257 (36.7) | 286 (41.4) | 258 (41.2) | |
III | 196 (48.3) | 333 (50.8) | 390 (55.7) | 343 (49.6) | 312 (49.8) | |
IV | 30 (7.4) | 44 (6.7) | 42 (6.0) | 33 (4.8) | 40 (6.4) | 0.34 |
Diabetes mellitus | 57 (14.0) | 105 (16.0) | 102 (14.6) | 108 (15.6) | 104 (16.6) | 0.38 |
Clinical characteristics | ||||||
Hospital length of stay, days | 14.7 (7.2) 14 (10; 17) | 13.4 (7.7) 13 (8; 17) | 12.2 (6.4) 11 (8; 15) | 10.6 (5.2) 10 (7; 13) | 9.75 (4.4) 9 (7; 12) | < 0.0001 |
Variables | Year 1, June 2015-May 2016 | Year 2, June 2016-May 2017 | Year 3, June 2017-May 2018 | Year 4, June 2018-May 2019 | Year 5, June 2019-March 2020 | p Over the periods |
---|---|---|---|---|---|---|
n = 406 | n = 655 | n = 700 | n = 691 | n = 626 | ||
Bladder distension | 165 (40.6) | 211 (32.2) | 154 (22.0) | 84 (12.2) | 57 (9.1) | <.00001 |
Urine volume ≥ 500 ml | 217 (71.1) n = 305 | 289 (65.1) n = 444 | 278 (49.5) n = 551 | 182 (28.1) n = 648 | 152 (28.4) n = 536 | < 0.0001 |
Largest volume observed during hospital stay | 606 (188) 600 (500; 700) n = 287 | 589 (190) 500 (450; 700) n = 419 | 536 (192) 500 (400; 600) n = 515 | 457.6 (159.7) 400 (350; 500) n = 602 | 459.2 (156.1) 400 (400; 500) n = 497 | < 0.0001 |
Indwelling urinary catheter | 114 (28.1) | 229 (35.0) | 396 (56.6) | 523 (75.7) | 493 (78.8) | < 0.0001 |
Straight in-out catheterisation | 150 (36.9) | 156 (23.8) | 76 (10.9) | 27 (3.9) | 17 (2.7) | < 0.0001 |
Indwelling and straight in-out catheterisation | 142 (35.0) | 270 (41.2) | 228 (32.6) | 141 (20.4) | 116 (18.5) | < 0.0001 |
Indwelling and straight in-out catheterisation + indwelling catheter | n = 256 | n = 499 | n = 624 | n = 664 | n = 609 | |
IDC days | 4.16 (3.95) 3 (2; 5) | 4.39 (4.47) 3 (2; 5) | 4.92 (5.16) 3 (2; 6) | 3.90 (3.10) 3 (2; 5) | 3.58 (3.26) 3 (2; 4) | 0.11 |
IDC re-insertion | 32 (12.5) | 78 (15.6) | 110 (17.6) | 76 (11.4) | 74 (12.2) | 0.083 |
IDC present on discharge Missing | 23 (9.0) | 56 (11.2) | 85 (13.6) 1 | 60 (9.0) | 49 (8.1) | 0.095 |
Straight in-out catheterisationa | 3.11 (3.17) 2 (1; 4) n = 292 | 2.79 (2.58) 2 (1; 4) n = 426 | 2.07 (1.58) 1 (1; 3) n = 304 | 1.68 (1.04) 1 (1; 2) n = 168 | 1.92 (1.43) 1 (1; 2) n = 133 | < 0.0001 |
Documentation | n = 256 | n = 499 | n = 624 | n = 664 | n = 609 | |
Urine volume when inserting an in-dwelling catheter | 17 (6.6) | 4 (0.8) | 335 (53.7) | 535 (80.6) | 452 (74.2) | < 0.0001 |
Documented indication | 117 (45.7) | 201 (40.3) | 387 (62.0) | 528 (79.5) | 472 (77.5) | < 0.0001 |
Documented removal plan | 17 (6.6) | 38 (7.6) | 147 (23.6) | 378 (56.9) | 225 (36.9) | < 0.0001 |
Univariablea | Multivariableb | |||||||
---|---|---|---|---|---|---|---|---|
Variable | n missing | Value | n (%) of event | OR (95%CI) bladder distension | p-value | Area under ROC curve (95%CI) | OR (95%CI) bladder distension | p-value |
Years | 0 | Year 1 | 165 (40.6) | |||||
Year 2 | 211 (32.2) | |||||||
Year 3 | 154 (22.0) | |||||||
Year 4 | 84 (12.2) | |||||||
Year 5 | 57 (9.1) | 0.60 (0.56–0.64) | < 0.0001 | 0.68 (0.66–0.70) | 0.61 (0.57–0.66) | < 0.0001 | ||
Gender | 0 | Female | 447 (20.5) | |||||
Male | 224 (24.9) | 1.28 (1.07–1.54) | 0.0082 | 0.53 (0.51–0.55) | 1.28 (1.05–1.56) | 0.013 | ||
Age+ | 0 | 65–80 | 208 (21.1) | |||||
81–88 | 233 (21.1) | |||||||
89–104 | 230 (23.3) | 1.06 (0.95–1.18) | 0.27 | 0.52 (0.49–0.54) | 1.08 (0.96–1.21) | 0.21 | ||
Hospital Length of stay++ | 0 | 3–8 | 158 (16.5) | |||||
9–13 | 228 (19.8) | |||||||
14–68 | 285 (29.5) | 1.36 (1.24–1.48) | < 0.0001 | 0.59 (0.57–0.62) | 1.16 (1.05–1.27) | 0.0019 | ||
Diabetes | 0 | yes | 110 (23.1) | |||||
no | 561 (21.6) | 0.91 (0.72–1.15) | 0.45 | 0.51 (0.49–0.52) | 0.89 (0.70–1.14) | 0.36 | ||
ASA score | 0 | 1 | 13 (15.3) | |||||
2 | 268 (21.8) | |||||||
3 | 353 (22.4) | |||||||
4 | 37 (19.6) | 1.03 (0.90–1.18) | 0.64 | 0.50 (0.48–0.53) | 0.96 (0.83–1.10) | 0.55 |